Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 160


Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.

Dampier W, Antell GC, Aiamkitsumrit B, Nonnemacher MR, Jacobson JM, Pirrone V, Zhong W, Kercher K, Passic S, Williams JW, James T, Devlin KN, Giovannetti T, Libon DJ, Szep Z, Ehrlich GD, Wigdahl B, Krebs FC.

J Neurovirol. 2016 Jul 11. [Epub ahead of print]


Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood-Brain Barrier.

Strazza M, Pirrone V, Wigdahl B, Dampier W, Lin W, Feng R, Maubert ME, Weksler B, Romero IA, Couraud PO, Nonnemacher MR.

Int J Mol Sci. 2016 Jun 9;17(6). pii: E916. doi: 10.3390/ijms17060916.


Co-culture model consisting of human brain microvascular endothelial and peripheral blood mononuclear cells.

Strazza M, Maubert ME, Pirrone V, Wigdahl B, Nonnemacher MR.

J Neurosci Methods. 2016 Aug 30;269:39-45. doi: 10.1016/j.jneumeth.2016.05.016. Epub 2016 May 20.


HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients.

Dampier W, Nonnemacher MR, Mell J, Earl J, Ehrlich GD, Pirrone V, Aiamkitsumrit B, Zhong W, Kercher K, Passic S, Williams JW, Jacobson JM, Wigdahl B.

PLoS One. 2016 May 19;11(5):e0155382. doi: 10.1371/journal.pone.0155382. eCollection 2016.


Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures.

Antell GC, Dampier W, Aiamkitsumrit B, Nonnemacher MR, Jacobson JM, Pirrone V, Zhong W, Kercher K, Passic S, Williams JW, Schwartz G, Hershberg U, Krebs FC, Wigdahl B.

Retrovirology. 2016 May 3;13(1):32. doi: 10.1186/s12977-016-0266-9.


HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity.

Nonnemacher MR, Pirrone V, Feng R, Moldover B, Passic S, Aiamkitsumrit B, Dampier W, Wojno A, Kilareski E, Blakey B, Ku TS, Shah S, Sullivan NT, Jacobson JM, Wigdahl B.

PLoS One. 2016 Apr 21;11(4):e0150835. doi: 10.1371/journal.pone.0150835. eCollection 2016.


Defining the roles for Vpr in HIV-1-associated neuropathogenesis.

James T, Nonnemacher MR, Wigdahl B, Krebs FC.

J Neurovirol. 2016 Aug;22(4):403-15. doi: 10.1007/s13365-016-0436-5. Epub 2016 Apr 7. Review.


HIV-1 Latency and Eradication: Past, Present and Future.

Datta PK, Kaminski R, Hu W, Pirrone V, Sullivan NT, Nonnemacher MR, Dampier W, Wigdahl B, Khalili K.

Curr HIV Res. 2016 Mar 24. [Epub ahead of print]


Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease.

Maubert ME, Pirrone V, Rivera NT, Wigdahl B, Nonnemacher MR.

Front Microbiol. 2016 Jan 11;6:1512. doi: 10.3389/fmicb.2015.01512. eCollection 2015. Review.


Biomarkers of HIV Susceptibility and Disease Progression.

Pirrone V, Mell J, Janto B, Wigdahl B.

EBioMedicine. 2014 Nov 7;1(2-3):99-100. doi: 10.1016/j.ebiom.2014.11.003. eCollection 2014 Dec. No abstract available.


Human Immunodeficiency Virus Type 1 Cellular Entry and Exit in the T Lymphocytic and Monocytic Compartments: Mechanisms and Target Opportunities During Viral Disease.

Aiamkitsumrit B, Sullivan NT, Nonnemacher MR, Pirrone V, Wigdahl B.

Adv Virus Res. 2015;93:257-311. doi: 10.1016/bs.aivir.2015.04.001. Epub 2015 May 8. Review.


HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a Cure.

Dampier W, Nonnemacher MR, Sullivan NT, Jacobson JM, Wigdahl B.

MOJ Immunol. 2014 Oct 17;1(4). pii: 00022.


Critical Review: Immunomodulation by Seminal Factors and Implications for Male-to-Female HIV-1 Transmission.

Keogan S, Siegert K, Wigdahl B, Krebs FC.

J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):131-7. doi: 10.1097/QAI.0000000000000561. Review.


Impact of viral activators and epigenetic regulators on HIV-1 LTRs containing naturally occurring single nucleotide polymorphisms.

Shah S, Pirrone V, Alexaki A, Nonnemacher MR, Wigdahl B.

Biomed Res Int. 2015;2015:320642. doi: 10.1155/2015/320642. Epub 2015 Jan 5.


Animal models of herpes simplex virus immunity and pathogenesis.

Kollias CM, Huneke RB, Wigdahl B, Jennings SR.

J Neurovirol. 2015 Feb;21(1):8-23. doi: 10.1007/s13365-014-0302-2. Epub 2014 Nov 12. Review.


Effect of μ-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells.

Strazza M, Banerjee A, Alexaki A, Passic SR, Meucci O, Pirrone V, Wigdahl B, Nonnemacher MR.

BMC Res Notes. 2014 Oct 23;7:752. doi: 10.1186/1756-0500-7-752.


Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.

Aiamkitsumrit B, Dampier W, Martin-Garcia J, Nonnemacher MR, Pirrone V, Ivanova T, Zhong W, Kilareski E, Aldigun H, Frantz B, Rimbey M, Wojno A, Passic S, Williams JW, Shah S, Blakey B, Parikh N, Jacobson JM, Moldover B, Wigdahl B.

PLoS One. 2014 Sep 29;9(9):e107389. doi: 10.1371/journal.pone.0107389. eCollection 2014.


Abasic phosphorothioate oligomers inhibit HIV-1 reverse transcription and block virus transmission across polarized ectocervical organ cultures.

Fraietta JA, Mueller YM, Lozenski KL, Ratner D, Boesteanu AC, Hancock AS, Lackman-Smith C, Zentner IJ, Chaiken IM, Chung S, LeGrice SF, Snyder BA, Mankowski MK, Jones NM, Hope JL, Gupta P, Anderson SH, Wigdahl B, Katsikis PD.

Antimicrob Agents Chemother. 2014 Dec;58(12):7056-71. doi: 10.1128/AAC.02991-14. Epub 2014 Sep 15.


Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I.

Shah S, Alexaki A, Pirrone V, Dahiya S, Nonnemacher MR, Wigdahl B.

Virol J. 2014 May 16;11:92. doi: 10.1186/1743-422X-11-92.


Bioinformatic analysis of HIV-1 entry and pathogenesis.

Aiamkitsumrit B, Dampier W, Antell G, Rivera N, Martin-Garcia J, Pirrone V, Nonnemacher MR, Wigdahl B.

Curr HIV Res. 2014;12(2):132-61. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk